Comparison between Bombay Super Hybrid Seeds IPO and Dr Lalchandani Labs IPO.
Bombay Super Hybrid Seeds IPO is a SME Fixed Price IPO proposed to list at NSE SME while Dr Lalchandani Labs IPO is a SME Fixed Price proposed to list at BSE SME.
| Bombay Super Hybrid Seeds IPO | Dr Lalchandani Labs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Monarch Networth Capital Ltd. | Navigant Corporate Advisors Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Cameo Corporate Services Ltd. |
| Market Maker | Monarch Networth Capital Ltd. | NNM Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Bombay Super Hybrid Seeds IPO is up to ₹9.86 Cr whereas the issue size of the Dr Lalchandani Labs IPO is up to ₹3.98 Cr. The final issue price of Bombay Super Hybrid Seeds IPO is ₹60.00 per share and of Dr Lalchandani Labs IPO is ₹30.00 per share.
| Bombay Super Hybrid Seeds IPO | Dr Lalchandani Labs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹60.00 per share | ₹30.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 4000 shares |
| Fresh Issue Size | 16,44,000 shares | 13,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹9.86 Cr | up to ₹3.98 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 16,44,000 shares | 13,28,000 shares |
| Issue Size Total (Amount) | up to ₹9.86 Cr | up to ₹3.98 Cr |
Bombay Super Hybrid Seeds IPO opens on Apr 12, 2018, while Dr Lalchandani Labs IPO opens on Apr 25, 2018. The closing date of Bombay Super Hybrid Seeds IPO and Dr Lalchandani Labs IPO is Apr 17, 2018, and Apr 27, 2018, respectively.
| Bombay Super Hybrid Seeds IPO | Dr Lalchandani Labs IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Apr 12, 2018 | Apr 25, 2018 |
| Issue Close | Apr 17, 2018 | Apr 27, 2018 |
| Basis Of Allotment (Tentative) | Apr 20, 2018 | |
| Initiation of Refunds (Tentative) | Apr 23, 2018 | |
| Credit of Share (Tentative) | Apr 24, 2018 | |
| Listing date (Tentative) | Apr 25, 2018 | May 09, 2018 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bombay Super Hybrid Seeds IPO P/E ratio is , as compared to Dr Lalchandani Labs IPO P/E ratio of .
| Bombay Super Hybrid Seeds IPO | Dr Lalchandani Labs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Bombay Super Hybrid Seeds IPO Retail Individual Investors (RII) are offered 8,22,000 shares while in Dr Lalchandani Labs IPO retail investors are offered 8,22,000 shares. Qualified Institutional Buyers (QIB) are offered in Bombay Super Hybrid Seeds IPO and in Dr Lalchandani Labs IPO.
| Bombay Super Hybrid Seeds IPO | Dr Lalchandani Labs IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 88,000 shares | 72,000 shares |
| QIB | ||
| NII | 8,22,000 shares | 6,64,000 shares |
| RII | 8,22,000 shares | 6,64,000 shares |
| Employee | ||
| Others | ||
| Total | 16,44,000 shares | 13,28,000 shares |
Bombay Super Hybrid Seeds IPO subscribed 9.67x in total, whereas Dr Lalchandani Labs IPO subscribed 4.96x.
| Bombay Super Hybrid Seeds IPO | Dr Lalchandani Labs IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 4.56x | 3.35x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 14.45x | 6.48x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 9.67x | 4.96x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
